AMENDMENT TO KEY COMPANY STOCKHOLDER FORWARD PURCHASE AGREEMENTKey Company Stockholder Forward Purchase Agreement • January 4th, 2023 • Peak Bio, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 4th, 2023 Company IndustryThis Amendment to Key Company Stockholder Forward Purchase Agreement (this “Amendment”) is made as of December 29, 2022 (the “Effective Date”) by and between Peak Bio, Inc. (f/k/a Ignyte Acquisition Corp.), a Delaware corporation (the “Company”), and Hoyoung Huh, M.D., Ph.D. (the “Investor”).